Heart transplantation with generic immunosuppression – a developing country experience
نویسندگان
چکیده
منابع مشابه
Heart transplantation with generic immunosuppression – a developing country experience
Results Ischemic or dilated cardiomyopathy were the main indications (23(43%) each), age 48+13 years and 48(91%) were male. Transplant listing Status: IA 14(26%)(VAD or 2 inotropes), IB 14(26%)(1 inotrope) and II 25 (47%) (no inotrope). Mean waiting time 70+83 days. Twelve (24%) were transplanted during VAD support (median support: 36 days). Operative technique: orthotopic bicaval transplant wi...
متن کاملBone marrow transplantation in patients with storage diseases: a developing country experience.
Bone marrow transplantation (BMT) is a therapeutic option for patients with genetic storage diseases. Between 1979 and 2002, eight patients, four females and four males (1 to 13 years old) were submitted to this procedure in our center. Six patients had mucopolysaccharidosis (MPS I in 3; MPS III in one and MPS VI in 2), one had adrenoleukodystrophy (ALD) and one had Gaucher disease. Five patien...
متن کامل20-year experience with pediatric heart transplant in a developing country
Results The mean age at transplantation was 5.9 years (min=12 days, max=18 years). The preoperative diagnosis was cardiomyopathy in 79% and congenital heart disease in 21%. The surgical technique for all cases was orthotopic transplantation, having been used the biatrial method until 1996 and, since then, the bicaval method. There were four retransplantation, three due to hyperacute rejection a...
متن کاملCaries experience in young children with congenital heart disease in a developing country.
Oral care is frequently suboptimal in children from developing countries, especially those suffering from severe systemic diseases. The aim of the present study was to analyze the oral epidemiological profile of 3-to-5-year-old children with congenital heart disease. Dental and medical records of children evaluated at the Dental Service of the National Institute of Cardiology, Rio de Janeiro, B...
متن کاملTen Years Experience With Belatacept-Based Immunosuppression After Kidney Transplantation
BACKGROUND Belatacept was approved for prevention of acute rejection in adult kidney transplantation in 2011 based on two randomized, controlled, multicenter phase 3 studies. Long-term experience over 10 years with belatacept-based immunosuppression after kidney transplantation has not been reported before. PATIENTS AND METHODS Analyzed were 20 patients who had been included into a randomized...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Cardiothoracic Surgery
سال: 2013
ISSN: 1749-8090
DOI: 10.1186/1749-8090-8-s1-o157